IL10 and metastatic malignant neoplasm in the lymph nodes: In addition, with the development of LSCC, higher IL-10 plasma levels and higher OR values of the −592 A/C, −819 T/C, −1082 A/G polymorphisms were found in the advanced LSCC patients and the patients with lymph node metastasis.